Variation in Gut Microbiota Strongly Influences Individual Rodent Phenotypes
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Understanding genetic and phenotypic differences between experimental animals (both within a single population and between populations held at different sites) is potentially important in explaining variability in responses to drugs and other stressors. Population changes in endogenous and exogenous metabolism in laboratory animal colonies have often been ascribed to genetic drift in the experimental animals themselves. This undoubtedly occurs in laboratory rodents; however, phenotypic drift in animal colonies can have an immediate and potentially greater short term impact on normal physiological variation and mammalian metabolism, as exemplified by Robosky et al. in this issue of Toxicological Sciences. They describe clear and stable metabolic differentiation of two groups of rats of identical strain obtained from the same supplier, but housed in separate rooms within the supplier's barrier unit. These observations were based on urinary metabolite signatures defined by 1H NMR spectroscopy and mass spectrometry (MS), which comprise thousands of low-molecular-weight molecules in a range of concentrations that can be profiled and interpreted using computer-based pattern recognition methods. The two distinct room-dependent phenotypes were predominantly distinguished by their major gut microbial mammalian co-metabolites, hippurate and 3-hydroxyphenylpropionic acid, indicating that animals in different locations were exposed to different microflora. Further minor metabolite differences between the two phenotypes were identified, giving a robust characterization of each phenotype. It is not known which of the two phenotypes described in this study are more representative of the strain, although most research articles showing NMR urinary profiles report hippurate (benzoyl glycine) as the dominant aromatic gut microbial-mammalian co-metabolite profile of both Sprague Dawley and Han Wistar rats (Gavaghan et al., 2000; Phipps et al., 1998). Moreover, the direct effects of different microbial communities on drug metabolism are unknown. The metabolite profiles for each phenotype were shown to be stable for at least 1 year, indicating the effectiveness of the animal husbandry procedures. Robosky et al. go on to show that, on transferring animals from one room to the other, the urinary metabolite profile rapidly accommodated to match the dominant profile of the animals already resident there, such that animals originally excreting a greater ratio of chlorogenic acid metabolites to hippurate predominantly excreted hippurate after changing their location. On isolation of the transferred animals, the animals retained the newly acquired metabolite profile rather than reverting to their original metabolite excretion pattern, indicating that the change in microbial composition or activity resulted in the production of an ecologically stable population. Conflicting reports have been published regarding the perseverance of nutritionally or drug-modified microflora in humans, with some evidence for longer-term stability of the newly acquired microflora after altering the urinary microbial excretion product profile (Wang et al., 2005). Other studies have shown a reversal of the intervention-induced microflora changes (Tannock et al., 2000). This is of potentially great significance, as the two different co-metabolic phenotypes of the same animal strain are likely to have different drug metabolizing capabilities and may show different toxicological susceptibilities. The potential for such gut microbial variations to have an influence on drug metabolism and toxicity in man and animals has recently been reviewed (Nicholson et al., 2004, 2005), and therefore, this experimental study is particularly timely as it indicates that significant microbial variation in laboratory rodents is probably very common. Intestinal microflora have variously been associated both with the production of toxic or genotoxic metabolites from drugs and food components (Kassie et al., 2001; Upreti et al., 2004) and also with the detoxification of other chemicals, such as chromium complexes (Kuroda et al., 2004). The role of changing symbiotic mammalian–microbial relationships in toxicology studies is poorly understood, and its impact little appreciated. However, the importance has been well documented in other areas, and a renewal of interest in the impact of symbiont microbes on mammalian health has lead to recent publications showing the association of particular strains of microbe with insulin resistance, autism, Crohn's disease, and other disorders of the GI tract, food allergies, cardiovascular disease, insulin resistance, and certain cancers (Dunne, 2001). The gut microbes act in many ways that could impact on drug toxicity and carcinogenicity. First, many have a significant capability for metabolism of numerous endogenous and drug-related compounds; for example, the large intestine contains a complex and diverse microbial population demonstrating a leve
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut microorganisms, mammalian metabolism and personalized health care
Nicholson, J. K., Holmes, E., & Wilson, I. D. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1152 · Cited by 945
Self-citationKassie, F. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1721 · Cited by 70
Cited by
Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601056103 · Cited by 1,042
Self-citationA top‐down systems biology view of microbiome‐mammalian metabolic interactions in a mouse model
Martin, F. J., Dumas, M., Wang, Y., Legido‐Quigley, C., Yap, I. K. S., Tang, H., Zirah, S., Murphy, G. M., Cloarec, O., Lindon, J. C., et al. (2007) · Molecular Systems Biology · doi:10.1038/msb4100153 · Cited by 474
Self-citationMartin, F. J., Wang, Y., Sprenger, N., Yap, I. K. S., Lundstedt, T., Lek, P., Rezzi, S., Ramadan, Z., van Bladeren, P., Fay, L. B., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb4100190 · Cited by 421
Self-citationGlobal systems biology, personalized medicine and molecular epidemiology
Nicholson, J. K. (2006) · Molecular Systems Biology · doi:10.1038/msb4100095 · Cited by 388
Self-citationSystemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes
Claus, S. P., Tsang, T. M., Wang, Y., Cloarec, O., Skordi, E., Martin, F., Rezzi, S., Ross, A., Kochhar, S., Holmes, E., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.56 · Cited by 334
Self-citation
Metadata
- Authors
- Holmes, E., & Nicholson, J.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 87
- Issue
- 1
- Pages
- 1-2
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2142617797
- Cited by
- 42
- References
- 2
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.